Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 FacebookTwitterPinterestEmail previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Expanded ExxonMobil Award Validates RemSense Strategy December 22, 2025 Silver Dollar Resources: Advancing High-grade Silver-Gold Assets in... December 22, 2025 Nickel Price 2025 Year-End Review December 22, 2025 Editor’s Picks: Silver Price Keeps Running, Breaks All-time... December 21, 2025 Tech Weekly: Micron Rises on Latest Results, Trump... December 21, 2025 John Feneck: Gold, Silver in 2026, Plus 9... December 20, 2025 Denison, Skyharbour Finalize Saskatchewan Uranium Joint Venture Deal December 20, 2025 Palladium Price Forecast: Top Trends for Palladium in... December 20, 2025 Armory Mining Announces Closing of Flow-Through Financing December 20, 2025 Platinum Price Forecast: Top Trends for Platinum in... December 20, 2025